Mesenchymal differentiation of glioblastoma stem cells

Cell Death and Differentiation

Volumn 15, Issue 9, 2008, Pages 1491-1498

  Ricci Vitiani, L ^a   Pallini, R ^b   Larocca, L M ^b   Lombardi, D G ^c   Signore, M ^a   Pierconti, F ^b   Petrucci, G ^b   Montano, N ^b   Maira, G ^b   De Maria, R ^a,c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c Mediterranean Institute of Oncology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STEM CELL; CELL CLONE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MITOSIS INDEX; MOUSE; MULTIPOTENT STEM CELL; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ADULT; AGED; ANIMALS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CLONE CELLS; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MESODERM; MICE; MICE, SCID; MIDDLE AGED; NEOPLASTIC STEM CELLS; NEURONS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 49949099841     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.72     Document Type: Article

References (46)

1. Zhu Y, Parada LF. The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002; 2: 616-626.
2. Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS et al Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 2001; 61: 4956-4960.
3. Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO. Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 2001; 61: 6674-6678.
4. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999; 97: 527-538.
5. Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas. Clin Cancer Res 2002; 8: 1117-1124.
6. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828.
7. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-7021.
8. Tunici P, Bissola L, Lualdi E, Pollo B, Cajola L, Broggi G et al. Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma. Mol Cancer 2004; 3: 25.
9. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
10. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737.
11. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005; 353: 811-822.
12. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006; 355: 1253-1261.
13. Vescovi AL, Galli R, Reynolds BA. Brain tumour stemcells. Nat Rev Cancer 2006; 6: 425-436.
14. Fomchenko EI, Holland EC. Stem cells and brain cancer. Exp Cell Res 2005; 306: 323-329.
15. Galli R, Borello U, Gritti A, Minasi MG, Bjornson C, Coletta M et al Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 2000; 3: 986-991.
16. Wurmser AE, Nakashima K, Summers RG, Toni N, D'Amour KA, Lie DC et al Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 2004; 430: 350-356.
17. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006; 444: 761-765.
18. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci USA 2002; 99: 4397-4402.
19. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1 (II) collagen gene. Mol Cell Biol 1997; 17: 2336-2346.
20. Tanaka H, Murphy CL, Murphy C, Kimura M, Kawai S, Polak JM. Chondrogenic differentiation of murine embryonic stem cells: Effects of culture conditions and dexamethasone. J Cell Biochem 2004; 93: 454-462.
21. McComb RD, Jones TR, Pizzo SV, Bigner DD. Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed glioma-sarcoma. J NeuroDathol Exp Neurol 1982; 41: 479-489.
22. Russel, Rubinstein: Pathology of Tumors of the Nervous System 1972
23. Louis DN, Ohgaki H, Wiestler OD, Cavenne WK. Gliosarcoma: WHO Classification of Tumors of the Central Nervous System. Geneva: WHO Press. 2007. pp 48-49.
24. Pallini R, Pierconti F, Falchetti ML, D'Arcangelo D, Fernandez E, Maira G et al. Evidence for telomerase involvement in the angiogenesis or astrocytic tumors: Expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells. J Neurosurg 2001; 94: 961-971.
25. Borota UG, Scheie D, Bjerkhagen B, Jacobsen EA, Skullerud K. Gliosarcoma with liposarcomatous component, bone infiltration and extracranial growth. Clin Neuropathol 2006; 25: 200-203.
26. Kleinschmidt-DeMasters BK, Meltesen L, McGavran L, Lillehei KO. Characterization of glioblastomas in young adults. Brain Pathol 2006; 16: 273-286.
27. Wyatt-Ashmead J, Kleinschmidt-DeMasters BK, Hill DA, McGavran L, Thompson S, Foreman NK et al. Rhabdoid glioblastoma. Clin Neuropathol 2001; 20: 248-255.
28. Philips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD et al Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006: 9: 157-173.
29. Tso CL, Shintaku P, Chen J, Liu Q, Liu J, Chen Z et al. Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res 2006; 4: 607-619.
30. Lee J. Kotliarova S. Kotliarov Y. Li A. Su Q. Donin NM et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391-403.
31. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR et al. Analysis of gene espression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67.
32. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage responce. Nature 2006; 444: 756-760.
33. Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G et al Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006; 13: 1238-1241.
34. Ginestier G, Hur MH, Charafe-Jauffret E, Monville F, Dutcheri, Brown M et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567.
35. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115.
36. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgolio A et al Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15: 504-514.
37. Kleihues P, Cavenee WK (eds) 'Pathology and Genetics of Tumours of the Nervous System.' World Health Organization Classification of Tumours, 2nd edn. Lyon, France: ARC Press: Pathology and Genetics of Tumours of the Nervous System 2000.
38. Falchetti ML, Pierconti F, Casalbore P, Maggiano N, Levi A, Larocca LM et al. Glioblastoma induces vascular endothelial cells to express telomerase in vitro. Cancer Res 2003; 63: 3750-3754.
39. Vojtesek B, Bartek J, Midgley CA, Lane DP. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992: 151: 237-244.
40. Jones H, Steart PV, Weller RO. Spindle-cell glioblastoma or gliosarcoma? Nueropathol Appl Neurobiol 1991; 17: 177-187.
41. Cheno Y. Ng HK. Dino M. Zhang SF, Pano JC, Lo KW. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors. J Neuropathol Exp Neurol 1999; 58: 120-128.
42. Newcomb EW, Cohen H, Lee SR, Bhalla SK, Bloom J, Hayes RL et al. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bc1-2 genes. Brain Pathol 1998; 8: 655-667.
43. Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV et al. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin Cancer Res 2002; 8: 2894-2901.
44. Paternoster SF, Brockman SR, McClure RF, Remstein ED, Kurtin PJ, Dewald GW. A new method to extract nuciel from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. Am J Pathol 2002: 160: 1967-1972.
45. Pagano SF, Impagnatiello F, Girelli M, Cova L, Grioni E, Onofri M et al. isolation and characterization of neural stem cells from the adult human olfactory bulb. Stem Cells 2000; 18: 295-300.
46. Lin Y, Luo E, Chen X, Liu L, Qia J, Yan Z et al. Molecular and cellular characterization during chondrogenic differentiation of adipose tissue-derived stromal cells in vitro and cartilage formation in vivo. J Cell Mol Med 2005; 9: 929-939.